12 Biotechnology Stocks Moving In Thursday's Pre-Market Session

Gainers

• Miragen Therapeutics, Inc. MGEN stock surged 63.9% to $2.77 during Thursday's pre-market session. The most recent rating by Baird, on December 12, is at Neutral, with a price target of $1.00.

• Novus Therapeutics, Inc. NVUS shares rose 33.3% to $0.80. The most recent rating by H.C. Wainwright, on November 27, is at Buy, with a price target of $2.00.

• Inovio Pharmaceuticals, Inc. INO stock increased by 15.8% to $4.76. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.

• Vaxart, Inc. VXRT shares surged 8.2% to $0.78.

• Cleveland BioLabs, Inc. CBLI stock rose 8.1% to $2.41.

• Kadmon Holdings, Inc. KDMN stock moved upwards by 6.9% to $4.80. The most recent rating by Nomura Instinet, on January 10, is at Buy, with a price target of $10.00.

• Soligenix, Inc. SNGX shares rose 6.4% to $2.81.

• Novavax, Inc. NVAX stock increased by 3.2% to $7.06.

Losers

• Conatus Pharmaceuticals, Inc. CNAT stock plummeted 14.0% to $0.40 during Thursday's pre-market session.

• DBV Technologies, Inc. DBVT stock plummeted 8.6% to $10.36. The most recent rating by Stifel, on January 09, is at Buy, with a price target of $18.00.

• Catabasis Pharmaceuticals, Inc. CATB stock decreased by 6.3% to $5.31.

• Genprex, Inc. GNPX shares decreased by 4.4% to $1.51.